from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3279c/birA

LFCtreatmentdescriptionclass of inhibitor

0.187

Amikacinug/mL Amikacintranslation

-0.130

Cap5-10ug/mL Capreomycintranslation

-0.798

Rox10-50 ug/mL Roxithromycintranslation

0.004

SM2-5 ug/mL Streptomycintranslation

-0.069

Tet5-10 ug/mL Tetracyclinetranslation

0.497

Rif0.2-5ug/mL Rifampicintranscription

-0.583

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.299

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.207

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.094

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.183

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.444

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.695

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.730

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.894

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.774

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.735

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.080

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.668

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.073

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.281

KCN5-20 ug/mL Potassium cyaniderespiration

-0.364

NaN30.2-2 mM Sodium aziderespiration

-0.042

Nigericin50 uM Nigericinrespiration

0.294

TRC10-150 ug/mL Triclosanrespiration

0.497

TRZ10-25 ug/mL Thioridazinerespiration

-0.752

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.187

menadione6-10 ug/mL Menadionerespiration

0.512

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.100

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.075

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.189

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.121

NRP_1Non-replicating persistence stage 1dosRassociated

-0.080

Amp0.2mg/mL AmpicillincellWall

-0.042

Cephalexin20-100 ug/mL CephalexincellWall

-0.057

Cerulenin0.32-5 ug/mL CerulenincellWall

0.545

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.359

EMB10-20 ug/mL EthambutolcellWall

0.334

Eta12-40 ug/mL EthionamidecellWall

0.357

INH0.2-0.4 ug/mL IsoniazidcellWall

0.375

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.812

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.920

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.558

BZA0.12 mg/mL BenzamidearomaticAmides

-0.108

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.207

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.099

H2O24 mM hydrogen peroxideDNAdamaging

0.078

Levo10 ug/mL LevofloxacinDNAdamaging

0.459

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.682

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.095

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.389

UVUV-irradiationDNAdamaging

0.977

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.062

Antimycin12.5-50 ug/mL Antimycin A?

-0.319

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.111

PA_110-50 ug/mL Antitubercular compound PA-1?

0.911

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.486

PA8240.2-2 ug/mL PA-824?

-0.490

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.143

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.009

Verapamil50 uM Verapamil?

0.432

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.180

methoxatin10-20 ug/mL Methoxatin?